19-17824811-CA-C
Position:
Variant summary
Our verdict is Benign. Variant got -9 ACMG points: 0P and 9B. BP6BS1BS2
The NM_000215.4(JAK3):c.*1931delT variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00692 in 194,902 control chromosomes in the GnomAD database, including 7 homozygotes. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Genomes: 𝑓 0.0066 ( 6 hom., cov: 33)
Exomes 𝑓: 0.0079 ( 1 hom. )
Consequence
JAK3
NM_000215.4 3_prime_UTR
NM_000215.4 3_prime_UTR
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: -0.337
Genes affected
JAK3 (HGNC:6193): (Janus kinase 3) The protein encoded by this gene is a member of the Janus kinase (JAK) family of tyrosine kinases involved in cytokine receptor-mediated intracellular signal transduction. It is predominantly expressed in immune cells and transduces a signal in response to its activation via tyrosine phosphorylation by interleukin receptors. Mutations in this gene are associated with autosomal SCID (severe combined immunodeficiency disease). [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -9 ACMG points.
BP6
Variant 19-17824811-CA-C is Benign according to our data. Variant chr19-17824811-CA-C is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 328461.We mark this variant Likely_benign, oryginal submissions are: {Uncertain_significance=2, Benign=1}.
BS1
Variant frequency is greater than expected in population nfe. gnomad4 allele frequency = 0.00664 (1012/152304) while in subpopulation NFE AF= 0.0104 (707/68028). AF 95% confidence interval is 0.00976. There are 6 homozygotes in gnomad4. There are 442 alleles in male gnomad4 subpopulation. Median coverage is 33. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 6 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
JAK3 | NM_000215.4 | c.*1931delT | 3_prime_UTR_variant | 24/24 | ENST00000458235.7 | NP_000206.2 | ||
JAK3 | XM_047438786.1 | c.*1931delT | 3_prime_UTR_variant | 24/24 | XP_047294742.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
JAK3 | ENST00000458235 | c.*1931delT | 3_prime_UTR_variant | 24/24 | 5 | NM_000215.4 | ENSP00000391676.1 | |||
JAK3 | ENST00000527031.5 | n.2777delT | non_coding_transcript_exon_variant | 14/14 | 2 | |||||
JAK3 | ENST00000696967.1 | n.4483delT | non_coding_transcript_exon_variant | 19/19 |
Frequencies
GnomAD3 genomes AF: 0.00664 AC: 1011AN: 152186Hom.: 6 Cov.: 33
GnomAD3 genomes
AF:
AC:
1011
AN:
152186
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.00789 AC: 336AN: 42598Hom.: 1 Cov.: 0 AF XY: 0.00801 AC XY: 159AN XY: 19842
GnomAD4 exome
AF:
AC:
336
AN:
42598
Hom.:
Cov.:
0
AF XY:
AC XY:
159
AN XY:
19842
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00664 AC: 1012AN: 152304Hom.: 6 Cov.: 33 AF XY: 0.00593 AC XY: 442AN XY: 74482
GnomAD4 genome
AF:
AC:
1012
AN:
152304
Hom.:
Cov.:
33
AF XY:
AC XY:
442
AN XY:
74482
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Asia WGS
AF:
AC:
7
AN:
3478
ClinVar
Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:2Benign:1
Revision: criteria provided, conflicting classifications
LINK: link
Submissions by phenotype
not provided Uncertain:1Benign:1
Benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Apr 01, 2023 | JAK3: BS1, BS2 - |
Uncertain significance, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Severe combined immunodeficiency disease Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jun 14, 2016 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at